Comprehensive Financial Consultants Institutional Inc. Acquires 9,869 Shares of UnitedHealth Group Incorporated $UNH

Comprehensive Financial Consultants Institutional Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, Holdings Channel.com reports. The fund bought 9,869 shares of the healthcare conglomerate’s stock, valued at approximately $3,623,000.

Several other large investors have also recently bought and sold shares of UNH. Wellington Altus USA Inc. grew its position in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak bought a new position in shares of UnitedHealth Group during the 2nd quarter worth about $29,000. Nvwm LLC raised its position in shares of UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 33 shares during the last quarter. Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at about $31,000. Finally, Nalls Sherbakoff Group LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $407.45 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The firm’s 50-day simple moving average is $387.17 and its 200-day simple moving average is $384.52. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The firm has a market cap of $365.72 billion, a P/E ratio of 23.27, a price-to-earnings-growth ratio of 1.43 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the firm posted $2.59 earnings per share. The firm’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 20.66 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday. Wells Fargo & Company raised their price objective on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Oppenheimer lifted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. TD Cowen restated a “hold” rating and set a $402.00 price objective on shares of UnitedHealth Group in a research report on Thursday. Finally, Evercore upped their target price on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a research note on Tuesday, July 7th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $461.48.

Insider Buying and Selling

In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat expectations: UnitedHealth reported adjusted EPS of $4.69 versus the $4.14 consensus estimate and revenue of $112.7 billion versus $111.31 billion expected. Revenue was roughly flat year over year, but profitability improved significantly. UnitedHealth Stock Moves Higher: What’s Going On?
• Positive Sentiment: Higher earnings outlook: Management raised its 2026 adjusted earnings forecast to at least $20.50 per share, above its previous $19.50–$20.00 range. The guidance increase was the primary catalyst for the stock’s upward move. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
• Positive Sentiment: Margin recovery signals: The medical care ratio improved to 88.4%, while Optum generated $3.7 billion in earnings. Analysts also cited pricing discipline, benefit changes, care-delivery improvements and AI initiatives as potential supports for stronger 2027 growth. UNH Q3 Deep Dive: Margin Recovery and AI Initiatives Shape 2027 Outlook
• Positive Sentiment: Constructive analyst views: Goldman Sachs reportedly raised its price target to $506, while Piper Sandler maintained an overweight rating and lifted its target to $504. Mizuho also continues to view UNH as a top healthcare pick. Goldman Sachs raises UNH target price to $506
• Neutral Sentiment: Defensive appeal: UnitedHealth is being highlighted as a low-beta healthcare stock that could benefit from investor demand for defensive companies if inflation and energy costs remain elevated. 3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
• Negative Sentiment: Growth risks remain: Analysts flagged shrinking membership, pressure from commercial medical costs and Medicaid, and uncertainty surrounding Medicare participation. TD Cowen reaffirmed a hold rating with a $402 target, while other firms reduced targets despite maintaining generally positive ratings. UnitedHealth Beats on Earnings, But Investors Question Growth Path

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.